2020
DOI: 10.1038/s41371-020-0338-0
|View full text |Cite
|
Sign up to set email alerts
|

Circulating miR-3135b and miR-107 are potential biomarkers for severe hypertension

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
6
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
10

Relationship

2
8

Authors

Journals

citations
Cited by 14 publications
(6 citation statements)
references
References 35 publications
0
6
0
Order By: Relevance
“…In addition, miR-3656/EMT axis is required for gemcitabine-resistant in pancreatic cancer [13]. Previously, we proved that miR-3656 reduces NO generation and vWF cleavage, thereby retarding blood flow and potentially increasing blood pressure in hypertension [15,20]. In this paper, we established that miR-3656 injured endothelial cells by downregulating TFAP2C expression; furthermore, downregulated TFAP2C decreased KLF10 expression by binding to KLF10 promoter region.…”
Section: Discussionmentioning
confidence: 71%
“…In addition, miR-3656/EMT axis is required for gemcitabine-resistant in pancreatic cancer [13]. Previously, we proved that miR-3656 reduces NO generation and vWF cleavage, thereby retarding blood flow and potentially increasing blood pressure in hypertension [15,20]. In this paper, we established that miR-3656 injured endothelial cells by downregulating TFAP2C expression; furthermore, downregulated TFAP2C decreased KLF10 expression by binding to KLF10 promoter region.…”
Section: Discussionmentioning
confidence: 71%
“…Confirming the potential targets and their effects/pathways found by our miRDB and the GO analysis, our literature research yielded the first hints of their involvement in hemorheological abnormalities such as hypertension/coronary artery calcification ( hsa -miR-3135b), pulmonary arterial hypertension ( hsa -miR-584-5p), angiogenesis/hypoxia ( hsa -miR-12136), and damaged vascular smooth muscles ( hsa -miR-550a-3p) [ 41 , 42 , 43 , 44 , 45 , 46 ]. Since the control group was lighter than the patient group (72.28 ± 8.83 kg vs. 85.51 ± 16.87 kg), the hsa -miR-584-5p and hsa -miR-550a-3p results may be due to this difference, as both miRNAs have also been linked to obesity/insulin resistance [ 47 , 48 ].…”
Section: Discussionmentioning
confidence: 91%
“…Kim et al reported that genetic variant of CHRM3 with high genetic risk scores was associated with impaired insulin sensitivity in PCOS patients 31 . Shi et al suggested that miR‐3135b was a potential biomarker for severe hypertension 32 . Besides, differently expressed hsa‐miR‐3135b in PCOS has been reported previously 33,34 .…”
Section: Discussionmentioning
confidence: 92%